ACCELERATE is the first ever natural history research study for Castleman disease patients! If you are a patient, we encourage you to get involved and power our research!
Patients (and family members of deceased patients) can enroll by clicking the button below (or clicking here)! After you provide your name, phone number, and email, please check your email to finish registration. If you would prefer, you can also enroll into the study by telephone. Please call 215-349-5713 if you are interested.
NOTE: The password you use to register must be at least 8 characters long and include:
One number (0-9)
One lowercase letter (a-z)
One uppercase letter (A-Z)
One symbol character (any character not a number or letter)
If you have any additional questions, please email email@example.com or call 215-349-5713.
If you would like to speak to a ACCELERATE Patient Ambassador prior to registration, please contact Mileva at firstname.lastname@example.org.
To log back into the database, please click here.
If you have completed the ACCELERATE registration process and want to share feedback with us: Please fill out this brief survey.
If you are a Castleman disease physician anywhere in the world, please sign up for the CDCN physician network here. For physicians treating Castleman disease patients involved in the ACCELERATE Patient Research Study, please see ACCELERATE Physician Information.
Frequently Asked Questions
What is the purpose of the ACCELERATE Patient Research Study?
ACCELERATE is the first-ever global patient registry of Castleman disease! It is designed to collect medical information and patient-reported information about Castleman disease.
As a collaborative partnership between the CDCN, Janssen Pharmaceuticals, and the University of Pennsylvania, ACCELERATE will be an observational, web-based database that combines data from physicians and patients around the world to better understand this deadly disease and facilitate future research.
Who can participate?
ACCELERATE is a global research study for patients with Castleman disease. If you are a patient or a family member of a deceased patient with Castleman disease, you may be eligible to participate. Participation will require a pathology report that suggests “Castleman disease.” Participation in ACCELERATE is entirely voluntary.
What information can I provide to a patient who is interested in joining?